How is the Celldex Therapeutics Inc. today?

The Celldex Therapeutics Inc. today is trading in the down by -4.16% at 20.29.

How has Celldex Therapeutics Inc. performed historically?

The Celldex Therapeutics Inc. is currently trading down -4.16% on an intraday basis in the past week the index fell -1.02%. The index has been up 1.81% in the past quarter and fell -45.18% in the past year. You can view this in the overview section.

What is Celldex Therapeutics Inc. Annual Revenue?

Celldex Therapeutics Inc. Annual Revenue rose 1.99%, in the last year to $7.02 M. Its sector's average revenue growth for the last fiscal year was 8.52%.

What is Celldex Therapeutics Inc. Annual Net Profit?

Celldex Therapeutics Inc. Annual Net Profit fell 11.62% in the last year to $157.86 M. Its sector's average net profit growth for the last fiscal year was 3.76%.

What is Celldex Therapeutics Inc. Price to Earning Ratio?

Celldex Therapeutics Inc. Price to Earning Ratio is -7.53, which is negative.

What is Celldex Therapeutics Inc. Stock Price?

Celldex Therapeutics Inc. Stock Price fell 45.18% and underperformed its sector by 51.65% in the past year.

What is Celldex Therapeutics Inc. Quarterly Revenue?

Celldex Therapeutics Inc. Quarterly Revenue rose 345.51% YoY to $0.7 M. Its sector's average revenue growth YoY for the quarter was 8.7%.

What is Celldex Therapeutics Inc. Quarterly Net profit?

Celldex Therapeutics Inc. Quarterly Net profit fell 63.97% YoY to $53.8 M. Its sector's average net profit growth YoY for the quarter was 24.68%.

What is Celldex Therapeutics Inc. Debt to Equity Ratio?

Celldex Therapeutics Inc. Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Celldex Therapeutics Inc. Return on Equity(ROE)?

Celldex Therapeutics Inc. Return on Equity(ROE) for the last financial year was -26.84%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Celldex Therapeutics Inc. Mutual Fund Holding?

Celldex Therapeutics Inc. Mutual Fund Holding decreased by 3.5% in the last quarter to 72.52.

What is Celldex Therapeutics Inc. Promoter Share Holding?

Celldex Therapeutics Inc. Promoter Share Holding stayed the same in the most recent quarter at 27.38%.

What is Celldex Therapeutics Inc. Institutional Holding?

Celldex Therapeutics Inc. Institutional Holding increased by 0.37% in the last quarter to 111.63.

MARKETS
SECTOR : DIVERSIFIED CONSUMER SERVICES
INDUSTRY : HEALTHCARE SERVICES
CELLDEX THERAPEUTICS INC.

Celldex Therapeutics Inc. XNAS: CLDX

Celldex Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Celldex Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Celldex Therapeutics Inc.
Rating: 1.27583325
Author: Trendlyne DVM scores

about

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products ta...

20.29 -0.88 (-4.16%)

56.83% Fall from 52W High

2.5M

XNAS Volume

XNAS 27 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

8.8 / 100

Technically Neutral

42.2 / 100

1Yr Price target upside is 189%

13 analysts

Celldex Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Celldex Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products ta...

56.83% Fall from 52W High

SWOT Analysis

Celldex Therapeutics Inc. Live Price Chart

Celldex Therapeutics Inc. FAQ

How is Celldex Therapeutics Inc. today?

Celldex Therapeutics Inc. today is trading in the red, and is down by -4.16% at 20.29.

How has Celldex Therapeutics Inc. performed historically?

Celldex Therapeutics Inc. is currently trading down -4.16% on an intraday basis. In the past week the stock fell -1.02%. stock has been up 1.81% in the past quarter and fell -45.18% in the past year. You can view this in the overview section.